US to spend US$3B for antiviral pills for COVID-19 – officialThursday, June 17, 2021
WASHINGTON, United States (AP) — The United States is devoting more than US$3 billion to advance development of antiviral pills for COVID-19, according to an official briefed on the matter.
The pills, which would be used to minimize symptoms after infection, are in development and could begin arriving by year's end, pending the completion of clinical trials.
The White House is scheduled to hold a briefing on its COVID-19 plans with Dr Anthony Fauci, the nation's top infectious disease expert.
News of the administration's plans for the pill was first reported Thursday by The New York Times. The official who confirmed the report spoke on the condition of anonymity ahead of an announcement.
Now you can read the Jamaica Observer ePaper anytime, anywhere. The Jamaica Observer ePaper is available to you at home or at work, and is the same edition as the printed copy available at https://bit.ly/epaper-login